JP Morgan Chase’s Counterpoint Quantitative Equity ETF CPAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$377K Sell
7,342
-73
-1% -$3.5K ﹤0.01% 5264
2026
Q1
$300K Buy
7,415
+313
+4% +$13.5K ﹤0.01% 5281
2025
Q4
$285K Buy
7,102
+641
+10% +$25.4K ﹤0.01% 5345
2025
Q3
$255K Buy
6,461
+331
+5% +$12.2K ﹤0.01% 5385
2025
Q2
$228K Buy
6,130
+286
+5% +$9.7K ﹤0.01% 5171
2025
Q1
$196K Buy
+5,844
New +$206K ﹤0.01% 5249

Other funds holding CPAI

JP Morgan Chase's CPAI Position: Q2 2026 in Review

JP Morgan Chase reduced its Counterpoint Quantitative Equity ETF (CPAI) stake by 0.98% in Q2 2026, selling an estimated $3.5K and leaving 7,342 shares worth $377K. The position accounts for ﹤0.01% of the portfolio, ranked #5264.

JP Morgan Chase first reported a position in CPAI in Q1 2025 and has held it in 6 quarters since. 54 funds tracked by Wall St. Rank hold CPAI as of Q2 2026.

  • JP Morgan Chase held 7,342 shares of Counterpoint Quantitative Equity ETF worth $377K as of Q2 2026.
  • JP Morgan Chase sold 73 Counterpoint Quantitative Equity ETF shares in Q2 2026, an estimated $3.5K.
  • Counterpoint Quantitative Equity ETF made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #5264 holding.
  • JP Morgan Chase first reported a position in Counterpoint Quantitative Equity ETF in Q1 2025 and has held it in 6 quarters since.
  • 54 funds tracked by Wall St. Rank held Counterpoint Quantitative Equity ETF as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.